Roivant Sciences
在场
Roivant Sciences 的所有者是 Sumitomo Chemical.
是其中之一......
Sumitomo Chemical 是一家在股票代码 4005 (JP) 下上市的公司。
Sumitomo Chemical 在 6 个国家有直接业务。Sumitomo Chemical 拥有 27家子公司，其中包括 Asahi Chemical、Covant Therapeutics 和 Datavant。
他们在：
高管
生物技术
Sumitomo Chemical 拥有 2,316 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- AgomAb Therapeutics 刚刚宣布为 89 筹款数百万美元。 (公布2024十月29号).
- Seaport Therapeutics 刚刚宣布为 225 筹款数百万美元。 (公布2024十月25号).
- TuHura Biosciences and Kintara Therapeutics have merged (公布2024十月20号)..
生物技术 行业的其他推荐联系人
消息
Roivant Sciences 的最新新闻稿
- Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1% | Roivant Sciences Ltd.
- Innovative Drugmaker Roivant Puts Up Really Healthy Sales Numbers
- Biotech Nears Breakout On This 'Extremely Positive' Development
- Roivant announces $1.5B share buyback, positive Phase 2 data (NASDAQ:ROIV)
- Risinger Recommends ‘Buy’ for Roivant Sciences with Optimistic Brepocitinib Revenue Forecast and Increased Price Target
- CinCor’s ‘hub-and-spoke’ parent nabs new funding to build its next biotechs
- Biohaven protein-degrader drug falls short of investor expectations in early-study test
- Biohaven protein-degrader drug falls short of investor expectations in early-study test
- CinRx Pharma Corrals $73M to Continue ‘Hub and Spoke’ Model of Startup Formation - MedCity News
- There's A Paradigm Shift In Immunology; And Big Pharma Is Paying Richly For It
- View more press releases Close
通过电子邮件
